Mark G. Foletta, a director at DexCom Inc. ($DXCM), sold shares on the open market five times in the last year, totaling nearly $686,000. His most recent sale occurred on August 15, 2025. These sales rank 5,791st among 11,678 individual insiders in our database, where the average is $8.6 million across about 6.4 transactions. Foletta made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 11, 2026 | ENANTA PHARMACEUTICALS INC | $ENTA | FOLETTA MARK G | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 29,019,344 | 9999.99% | 0.07% |
| Aug. 15, 2025 | DEXCOM INC | $DXCM | FOLETTA MARK G | Director | S | Common Stock | 2555 | $81.02 | 57,047.0000 | 412,700,000 | 4.29% | 0.00% |
| Aug. 15, 2025 | DEXCOM INC | $DXCM | FOLETTA MARK G | Director | S | Common Stock | 195 | $81.54 | 56,852.0000 | 412,700,000 | 0.34% | 0.00% |
| July 15, 2025 | DEXCOM INC | $DXCM | FOLETTA MARK G | Director | S | Common Stock | 2742 | $85.17 | 59,610.0000 | 412,700,000 | 4.40% | 0.00% |
| July 15, 2025 | DEXCOM INC | $DXCM | FOLETTA MARK G | Director | S | Common Stock | 8 | $86.03 | 59,602.0000 | 412,700,000 | 0.01% | 0.00% |
| June 16, 2025 | DEXCOM INC | $DXCM | FOLETTA MARK G | Director | S | Common Stock | 2750 | $83.13 | 62,352.0000 | 412,700,000 | 4.22% | 0.00% |
| May 8, 2025 | DEXCOM INC | $DXCM | FOLETTA MARK G | Director | G | Common Stock | 2973 | $0.00 | 65,102.0000 | 412,700,000 | 4.79% | 0.00% |
| May 8, 2025 | DEXCOM INC | $DXCM | FOLETTA MARK G | Director | G | Common Stock | 2973 | $0.00 | 59,371.0000 | 412,700,000 | 4.77% | 0.00% |
| May 8, 2025 | DEXCOM INC | $DXCM | FOLETTA MARK G | Director | A | Common Stock | 5731 | $0.00 | 65,102.0000 | 412,700,000 | 9.65% | 0.00% |
| May 2, 2025 | AMN HEALTHCARE SERVICES INC | $AMN | FOLETTA MARK G | Director | A | Restricted Stock Units | 8325 | $0.00 | 8,325.0000 | 50,819,000 | 9999.99% | 0.02% |
| April 19, 2025 | AMN HEALTHCARE SERVICES INC | $AMN | FOLETTA MARK G | Director | M | Restricted Stock Units | 3019 | $0.00 | 0.0000 | 50,819,000 | 100.00% | 0.01% |
| April 19, 2025 | AMN HEALTHCARE SERVICES INC | $AMN | FOLETTA MARK G | Director | M | Common Stock | 3019 | $0.00 | 13,273.0000 | 50,819,000 | 29.44% | 0.01% |
| March 13, 2025 | ENANTA PHARMACEUTICALS INC | $ENTA | FOLETTA MARK G | Director | A | Stock Option (right to buy) | 15700 | $0.00 | 15,700.0000 | 0 | 9999.99% | 0.00% |
| June 18, 2024 | DEXCOM INC | $DXCM | FOLETTA MARK G | Director | S | Common Stock | 3007 | $116.75 | 59,670.0000 | 425,500,000 | 4.80% | 0.00% |
| June 18, 2024 | DEXCOM INC | $DXCM | FOLETTA MARK G | Director | S | Common Stock | 299 | $117.25 | 59,371.0000 | 425,500,000 | 0.50% | 0.00% |
| June 17, 2024 | DEXCOM INC | $DXCM | FOLETTA MARK G | Director | S | Common Stock | 475 | $117.77 | 62,677.0000 | 425,500,000 | 0.75% | 0.00% |
| June 17, 2024 | DEXCOM INC | $DXCM | FOLETTA MARK G | Director | S | Common Stock | 2212 | $117.16 | 63,152.0000 | 425,500,000 | 3.38% | 0.00% |
| June 17, 2024 | DEXCOM INC | $DXCM | FOLETTA MARK G | Director | S | Common Stock | 7 | $115.18 | 65,364.0000 | 425,500,000 | 0.01% | 0.00% |
| May 22, 2024 | DEXCOM INC | $DXCM | FOLETTA MARK G | Director | A | Common Stock | 2973 | $0.00 | 65,371.0000 | 425,500,000 | 4.76% | 0.00% |
| May 18, 2024 | DEXCOM INC | $DXCM | FOLETTA MARK G | Director | G | Common Stock | 3306 | $0.00 | 62,398.0000 | 425,500,000 | 5.59% | 0.00% |
| May 18, 2024 | DEXCOM INC | $DXCM | FOLETTA MARK G | Director | G | Common Stock | 3306 | $0.00 | 62,398.0000 | 425,500,000 | 5.03% | 0.00% |
| April 19, 2024 | AMN HEALTHCARE SERVICES INC | $AMN | FOLETTA MARK G | Director | M | Restricted Stock Units | 1681 | $0.00 | 0.0000 | 50,537,000 | 100.00% | 0.00% |
| April 19, 2024 | AMN HEALTHCARE SERVICES INC | $AMN | FOLETTA MARK G | Director | M | Common Stock | 1681 | $0.00 | 10,254.0000 | 50,537,000 | 19.61% | 0.00% |
| April 19, 2024 | AMN HEALTHCARE SERVICES INC | $AMN | FOLETTA MARK G | Director | A | Restricted Stock Units | 3019 | $0.00 | 3,019.0000 | 50,537,000 | 9999.99% | 0.01% |
| March 6, 2024 | ENANTA PHARMACEUTICALS INC | $ENTA | FOLETTA MARK G | Director | A | Stock Option (right to buy) | 15700 | $0.00 | 15,700.0000 | 0 | 9999.99% | 0.00% |
| Feb. 29, 2024 | AMN HEALTHCARE SERVICES INC | $AMN | FOLETTA MARK G | Director | P | Common Stock | 500 | $56.90 | 8,573.0000 | 50,423,000 | 6.19% | 0.00% |